BR9913337A - Derivados tan-1057 - Google Patents
Derivados tan-1057Info
- Publication number
- BR9913337A BR9913337A BR9913337-7A BR9913337A BR9913337A BR 9913337 A BR9913337 A BR 9913337A BR 9913337 A BR9913337 A BR 9913337A BR 9913337 A BR9913337 A BR 9913337A
- Authority
- BR
- Brazil
- Prior art keywords
- derivatives
- tan
- man
- animals
- diseases
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000005445 natural material Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19838998A DE19838998A1 (de) | 1998-08-27 | 1998-08-27 | Neue Naturstoffderivate |
| PCT/EP1999/006124 WO2000012484A1 (de) | 1998-08-27 | 1999-08-20 | Tan-1057 derivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9913337A true BR9913337A (pt) | 2001-05-15 |
Family
ID=7878913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9913337-7A BR9913337A (pt) | 1998-08-27 | 1999-08-20 | Derivados tan-1057 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6617332B1 (https=) |
| EP (1) | EP1117652B1 (https=) |
| JP (1) | JP4533535B2 (https=) |
| KR (1) | KR20010099629A (https=) |
| CN (1) | CN1324348A (https=) |
| AT (1) | ATE267816T1 (https=) |
| AU (1) | AU759618B2 (https=) |
| BG (1) | BG105275A (https=) |
| BR (1) | BR9913337A (https=) |
| CA (1) | CA2342102C (https=) |
| DE (2) | DE19838998A1 (https=) |
| EE (1) | EE200100125A (https=) |
| ES (1) | ES2219105T3 (https=) |
| HK (1) | HK1041884A1 (https=) |
| HR (1) | HRP20010135A2 (https=) |
| HU (1) | HUP0103316A3 (https=) |
| ID (1) | ID28365A (https=) |
| IL (1) | IL141325A0 (https=) |
| NO (1) | NO20010940L (https=) |
| NZ (1) | NZ510153A (https=) |
| PL (1) | PL346143A1 (https=) |
| SK (1) | SK2622001A3 (https=) |
| TR (1) | TR200100637T2 (https=) |
| WO (1) | WO2000012484A1 (https=) |
| ZA (1) | ZA200101038B (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1113008A1 (en) * | 1999-12-29 | 2001-07-04 | Pfizer Products Inc. | 4-oxo-2-ureido-1,4,5,6-tetrahydro-pyrimidine derivatives useful as antibacterial and antiprotozoal agents |
| US20040204404A1 (en) * | 2002-09-30 | 2004-10-14 | Robert Zelle | Human N-type calcium channel blockers |
| CA2707790C (en) * | 2007-12-20 | 2015-04-21 | Dr. Reddy's Laboratories Limited | Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof |
| JP5725561B2 (ja) | 2009-10-15 | 2015-05-27 | 国立大学法人徳島大学 | ジエチレントリアミン五酢酸誘導体の製造方法およびジエチレントリアミン五酢酸誘導体 |
| KR101972992B1 (ko) | 2009-10-16 | 2019-04-29 | 멜린타 서브시디어리 코프. | 항미생물성 화합물 및 이의 제조 방법 및 사용 방법 |
| US9216979B2 (en) * | 2009-10-16 | 2015-12-22 | Melinta Therapeutics, Inc. | Antimicrobial compounds and methods of making and using the same |
| WO2011047320A2 (en) | 2009-10-16 | 2011-04-21 | Rib-X Pharmaceuticals, Inc. | Antimicrobial compounds and methods of making and using the same |
| TW201726630A (zh) * | 2009-10-16 | 2017-08-01 | 梅林塔療法公司 | 抗微生物性化合物及其製造與使用方法 |
| KR20140065378A (ko) | 2011-04-15 | 2014-05-29 | 멜린타 테라퓨틱스, 인크. | 항미생물 화합물 및 그의 제조 방법과 사용 방법 |
| RU2475479C1 (ru) * | 2011-12-23 | 2013-02-20 | Федеральное государственное бюджетное учреждение Министерства здравоохранения и социального развития Российской Федерации "Медицинский радиологический научный центр" (ФГБУ МРНЦ Минздравсоцразвития России) | Вазоконстрикторное средство |
| EP3038623A4 (en) | 2013-09-09 | 2017-04-19 | Melinta Therapeutics, Inc. | Antimicrobial compounds and methods of making and using the same |
| KR20160070066A (ko) | 2013-09-09 | 2016-06-17 | 멜린타 테라퓨틱스, 인크. | 항균 화합물, 및 이의 제조 방법 및 이용 방법 |
| CA2979342A1 (en) | 2015-03-11 | 2016-09-15 | Melinta Therapeutics, Inc. | Antimicrobial compounds and methods of making and using the same |
| WO2017193016A1 (en) | 2016-05-06 | 2017-11-09 | Melinta Therapeutics, Inc. | Antimicrobials and methods of making and using same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2873340B2 (ja) | 1988-04-29 | 1999-03-24 | 武田薬品工業株式会社 | 抗生物質ｔａｎ―１０５７，その製造法および用途 |
| WO1999007685A1 (en) | 1997-08-07 | 1999-02-18 | Research Corporation Technologies, Inc. | Antibiotic for methicillin resistant bacteria |
-
1998
- 1998-08-27 DE DE19838998A patent/DE19838998A1/de not_active Ceased
-
1999
- 1999-08-20 CA CA002342102A patent/CA2342102C/en not_active Expired - Fee Related
- 1999-08-20 AU AU10099/00A patent/AU759618B2/en not_active Ceased
- 1999-08-20 AT AT99968234T patent/ATE267816T1/de not_active IP Right Cessation
- 1999-08-20 ID IDW20010483A patent/ID28365A/id unknown
- 1999-08-20 DE DE59909607T patent/DE59909607D1/de not_active Expired - Lifetime
- 1999-08-20 ES ES99968234T patent/ES2219105T3/es not_active Expired - Lifetime
- 1999-08-20 HK HK02103758.4A patent/HK1041884A1/zh unknown
- 1999-08-20 EP EP99968234A patent/EP1117652B1/de not_active Expired - Lifetime
- 1999-08-20 CN CN99812643A patent/CN1324348A/zh active Pending
- 1999-08-20 NZ NZ510153A patent/NZ510153A/xx unknown
- 1999-08-20 KR KR1020017002417A patent/KR20010099629A/ko not_active Withdrawn
- 1999-08-20 HR HR20010135A patent/HRP20010135A2/hr not_active Application Discontinuation
- 1999-08-20 WO PCT/EP1999/006124 patent/WO2000012484A1/de not_active Ceased
- 1999-08-20 EE EEP200100125A patent/EE200100125A/xx unknown
- 1999-08-20 SK SK262-2001A patent/SK2622001A3/sk unknown
- 1999-08-20 TR TR2001/00637T patent/TR200100637T2/xx unknown
- 1999-08-20 HU HU0103316A patent/HUP0103316A3/hu unknown
- 1999-08-20 BR BR9913337-7A patent/BR9913337A/pt not_active IP Right Cessation
- 1999-08-20 JP JP2000567514A patent/JP4533535B2/ja not_active Expired - Fee Related
- 1999-08-20 PL PL99346143A patent/PL346143A1/xx not_active Application Discontinuation
- 1999-08-20 IL IL14132599A patent/IL141325A0/xx unknown
- 1999-08-20 US US09/763,711 patent/US6617332B1/en not_active Expired - Fee Related
-
2001
- 2001-02-07 ZA ZA200101038A patent/ZA200101038B/en unknown
- 2001-02-20 BG BG105275A patent/BG105275A/xx unknown
- 2001-02-23 NO NO20010940A patent/NO20010940L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20010940L (no) | 2001-04-23 |
| DE19838998A1 (de) | 2000-03-09 |
| HRP20010135A2 (en) | 2002-02-28 |
| CN1324348A (zh) | 2001-11-28 |
| JP4533535B2 (ja) | 2010-09-01 |
| NZ510153A (en) | 2002-12-20 |
| EP1117652B1 (de) | 2004-05-26 |
| DE59909607D1 (de) | 2004-07-01 |
| HK1041884A1 (zh) | 2002-07-26 |
| EE200100125A (et) | 2002-06-17 |
| IL141325A0 (en) | 2002-03-10 |
| AU1009900A (en) | 2000-03-21 |
| BG105275A (en) | 2001-11-30 |
| AU759618B2 (en) | 2003-04-17 |
| PL346143A1 (en) | 2002-01-28 |
| NO20010940D0 (no) | 2001-02-23 |
| JP2002523496A (ja) | 2002-07-30 |
| HUP0103316A2 (hu) | 2002-04-29 |
| ES2219105T3 (es) | 2004-11-16 |
| HUP0103316A3 (en) | 2002-06-28 |
| ATE267816T1 (de) | 2004-06-15 |
| ZA200101038B (en) | 2002-02-07 |
| CA2342102A1 (en) | 2000-03-09 |
| US6617332B1 (en) | 2003-09-09 |
| TR200100637T2 (tr) | 2001-10-22 |
| WO2000012484A1 (de) | 2000-03-09 |
| KR20010099629A (ko) | 2001-11-09 |
| SK2622001A3 (en) | 2001-11-06 |
| CA2342102C (en) | 2008-10-28 |
| EP1117652A1 (de) | 2001-07-25 |
| ID28365A (id) | 2001-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0311313A (pt) | Derivados de diaril uréia úteis para o tratamento de doenças dependentes de proteìna cinase | |
| BR9714363A (pt) | Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas | |
| BR9915208A (pt) | Preparado farmacêutico de moxifloxacina | |
| BR9913337A (pt) | Derivados tan-1057 | |
| ATE355374T1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| ATE339187T1 (de) | Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt | |
| BR9713363A (pt) | Epotilonas c, d, e e f, preparação e composições | |
| CY1111912T1 (el) | Μεθοδος αναστολης της δραστηριοτητας των οστεοκλαστων | |
| PA8657201A1 (es) | Compuestos de 3h-oxazolo y 3h-tiazolo [4, 5-d] pirimidin-2-ona 3, 5-disustituida y 3, 5, 7 - trisustituida y profarmacos de los mismos | |
| BRPI0519195A2 (pt) | composiÇço de cuidado oral, e, mÉtodo para prevenir ou tratar cÁrie dental em um indivÍduo humano ou animal | |
| BR0112591A (pt) | Derivados de acridina e sua aplicação como medicamento | |
| HN2000000115A (es) | Formulacion de sal comun y moxifloxacina | |
| HUP0100539A2 (hu) | D-vitamint és kálciumot tartalmazó gyógyászati készítmények és eljárás azok előállítására | |
| BR9808255A (pt) | Amidas de ácido aminossalicìlico substituìdas com efeito fungicida e produtos intermediários para sua preparação. | |
| PT758241E (pt) | Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses | |
| NO972391D0 (no) | 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav | |
| ES2153906T3 (es) | Uso de incienso para el tratamiento de la enfermedad de alzheimer. | |
| DE68929388D1 (de) | Aus Harn isolierte antikoagulierende Verbindung | |
| TR200101649T2 (tr) | Piperazin türevleri. | |
| FR2755965B1 (fr) | Composes biaromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations | |
| BR0012291A (pt) | Fenoxifluorpirimidinas | |
| BR0112807A (pt) | Derivados de indol e sua aplicação como medicamento | |
| BR0115883A (pt) | Derivados de ácido amino-furan-2-il-acético e ácido amino-tien-2-il-acético substituìdos e seu emprego para o tratamento de cefaléia ou dor | |
| BR9811939A (pt) | Metoximinometiloxadiazinas como pesticidas | |
| BG101605A (bg) | Ентерокинетични бензамиди |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5 A 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007. |